These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22187398)

  • 41. Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding.
    Carpenter SL; Abshire TC; Killough E; Anderst JD;
    Pediatrics; 2022 Oct; 150(4):. PubMed ID: 36120799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving blood disorder diagnosis: reflections on the challenges.
    Hayward CP
    Int J Lab Hematol; 2013 Jun; 35(3):244-53. PubMed ID: 23480102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Easy bruising and bleeding.
    Murtagh J
    Aust Fam Physician; 1992 Nov; 21(11):1671-6. PubMed ID: 1445005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?
    Cattaneo M
    J Thromb Haemost; 2004 Jun; 2(6):890-1. PubMed ID: 15140123
    [No Abstract]   [Full Text] [Related]  

  • 45. Common bleeding problems.
    Moake JL; Funicella T
    Clin Symp; 1983; 35(3):1-32. PubMed ID: 6336273
    [No Abstract]   [Full Text] [Related]  

  • 46. The clinical manifestations of bleeding.
    Schwartz SO
    Med Clin North Am; 1972 Jan; 56(1):17-24. PubMed ID: 4536634
    [No Abstract]   [Full Text] [Related]  

  • 47. [A systematic approach to the bleeding patient].
    Bösiger J
    Praxis (Bern 1994); 2004 Oct; 93(41):1693-9. PubMed ID: 15535603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Favaloro EJ
    J Thromb Haemost; 2004 Dec; 2(12):2280-2; author reply 2283-5. PubMed ID: 15613055
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research.
    Mezzano D; Quiroga T
    J Thromb Haemost; 2019 Feb; 17(2):257-270. PubMed ID: 30562407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal coagulation disorders and postpartum hemorrhage.
    Silver RM; Major H
    Clin Obstet Gynecol; 2010 Mar; 53(1):252-64. PubMed ID: 20142661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multicenter clinical evaluation of the Clot Signature Analyzer.
    Fricke W; Kouides P; Kessler C; Schmaier AH; Krijanovski Y; Jagadeesan K; Joist J
    J Thromb Haemost; 2004 May; 2(5):763-8. PubMed ID: 15099283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating for suspected child abuse: conditions that predispose to bleeding.
    Carpenter SL; Abshire TC; Anderst JD;
    Pediatrics; 2013 Apr; 131(4):e1357-73. PubMed ID: 23530171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to use a coagulation screen.
    Kapur S; Gilmore M; Macartney C; Thompson A
    Arch Dis Child Educ Pract Ed; 2022 Feb; 107(1):45-49. PubMed ID: 33637579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First-Step Results of Children Presenting with Bleeding Symptoms or Abnormal Coagulation Tests in an Outpatient Clinic.
    Yıldız İ; Ünüvar A; Kamer İ; Karaman S; Uysalol E; Kılıç A; Oğuz F; Ünüvar E
    Turk J Haematol; 2015 Dec; 32(4):338-43. PubMed ID: 26377979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic assessment of platelet disorders: what are the challenges to standardization?
    Pai M; Hayward CP
    Semin Thromb Hemost; 2009 Mar; 35(2):131-8. PubMed ID: 19408186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Review of patients studied for coagulopathy in a Hematology/Oncology unit].
    Romero I; Conde N; García Aldana D; Ruano A; Fernández-Teijeiro A
    An Pediatr (Barc); 2016 Feb; 84(2):85-91. PubMed ID: 26006274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ability of hemostatic assessment to detect bleeding disorders and to predict abnormal surgical blood loss in children: a systematic review and meta-analysis.
    Guay J; Faraoni D; Bonhomme F; Borel Derlon A; Lasne D
    Paediatr Anaesth; 2015 Dec; 25(12):1216-26. PubMed ID: 26467201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Principal symptoms in hemostasis disorders].
    Coninx S; Beck EA
    Schweiz Med Wochenschr; 1979 Feb; 109(5):137-41. PubMed ID: 312528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG; Hamilton GC
    Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.